Efficacy and safety of intravitreal pegcetacoplan in geographic atrophy: Results from the phase 3 DERBY and OAKS trials

被引：0
|
作者：
Guymer, Robyn H. [1 ]
Mitchell, Paul [2 ]
Wong, James [3 ]
Heier, Jeff [4 ]
Singh, Rishi [5 ]
Steinle, Nathan [6 ]
Boyer, David [7 ]
Mones, Jordie [8 ]
Staurenghi, Giovanni [9 ]
Holz, Frank [10 ]
Bliss, Caleb [11 ]
Deschatelets, Pascal [11 ]
Grossi, Federico [11 ]
Francois, Cedric [11 ]
Wykoff, Charlie [12 ]
Ribeiro, Ramiro [11 ]
机构：
[1] Univ Melbourne, Royal Victorian Eye & Ear Hosp, Ctr Eye Res Australia, Melbourne, Vic, Australia
[2] Sydney West Retina, Sydney, NSW, Australia
[3] Strathfield Retina Clin, Sydney, NSW, Australia
[4] Ophthalm Consultants Boston, Boston, MA USA
[5] Cleveland Clin, Cole Eye Inst, Cleveland, OH 44106 USA
[6] Retina Vitreous Associates Med Grp, Beverly Hills, CA USA
[7] Retina Vitreous Associates Med Grp, Los Angeles, CA USA
[8] Ctr Med Teknon, Barcelona, Spain
[9] Luigi Sacco Hosp, Milan, Italy
[10] Univ Augenklin Bonn, Bonn, Germany
[11] Apellis Pharmaceut, Waltham, MA USA
[12] Retina Consultants Texas, Dallas, TX USA
来源：
CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY | 2022年 / 49卷 / 08期
关键词：
D O I：
暂无
中图分类号：
R77 [眼科学];
学科分类号：
100212 ;
摘要：
引用
收藏
页码：833 / 833
页数：1
相关论文
共 50 条
  • [21] Methodological Appraisal of Phase 3 Clinical Trials in Geographic Atrophy
    Biarnes, Marc
    Garrell-Salat, Xavier
    Gomez-Benlloch, Alba
    Guarro, Merce
    Londono, Gabriel
    Lopez, Elena
    Ruiz, Sergi
    Vazquez, Meritxell
    Sararols, Laura
    BIOMEDICINES, 2023, 11 (06)
  • [22] Efficacy and Safety of Lampalizumab for Geographic Atrophy Due to Age-Related Macular Degeneration Chroma and Spectri Phase 3 Randomized Clinical Trials
    Holz, Frank G.
    Sadda, Srinivas R.
    Busbee, Brandon
    Chew, Emily Y.
    Mitchell, Paul
    Tufail, Adnan
    Brittain, Christopher
    Ferrara, Daniela
    Gray, Sarah
    Honigberg, Lee
    Martin, Jillian
    Tong, Barbara
    Ehrlich, Jason S.
    Bressler, Neil M.
    JAMA OPHTHALMOLOGY, 2018, 136 (06) : 666 - 677
  • [23] Efficacy and Safety of Ligelizumab in Chronic Spontaneous Urticaria: Results from the Phase3 Pivotal Trials
    Ensina, Luis Felipe
    Bernstein, Jonathan
    Sussman, Gordon
    Maurer, Marcus
    Gimenez-Arnau, Ana Maria
    Saini, Sarabjit
    Varanasi, Vineeth
    Barve, Avantika
    Hua, Eva
    Patekar, Manmath
    Severin, Thomas
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2023, 151 (02) : AB130 - AB130
  • [24] Visual Function Benefit After Treatment With Pegcetacoplan: Microperimetry Analysis From the Phase 3 Oaks Trial
    Chakravarthy, Usha
    Schwartz, Roy
    Guymer, Robyn h.
    Holz, Frank g.
    Rachitskaya, A. L. E. K. S. A. N. D. R. A. v
    Vujosevic, Stela
    Lewis, Philip
    Vorwerk, Hanne
    Alibhai, A. yasin
    Moult, Eric m.
    Morales, Marco u.
    Bliss, Caleb
    Baumal, Caroline r.
    Waheed, Nadia k.
    AMERICAN JOURNAL OF OPHTHALMOLOGY, 2025, 273 : 119 - 129
  • [25] Efficacy and Safety of Pegcetacoplan Treatment in Complement-Inhibitor Naive Patients with Paroxysmal Nocturnal Hemoglobinuria: Results from the Phase 3 Prince Study
    Wong, Raymond S.
    Navarro, Juan Ramon
    Comia, Narcisa Sonia
    Goh, Yeow Tee
    Idrobo, Henry
    Kongkabpan, Daolada
    Gomez-Almaguer, David
    Al-Adhami, Mohammed
    Ajayi, Temitayo
    Alvarenga, Paulo
    Deschatelets, Pascal
    Francois, Cedric
    Grossi, Federico
    Dumagay, Teresita
    BLOOD, 2021, 138
  • [26] Tapinarof cream for the treatment of plaque psoriasis: Efficacy and safety results from 2 Japanese phase 3 trials
    Igarashi, Atsuyuki
    Tsuji, Gaku
    Fukasawa, Shuichi
    Murata, Ryusei
    Yamane, Satoshi
    JOURNAL OF DERMATOLOGY, 2024, 51 (10): : 1269 - 1278
  • [27] Efficacy and Safety of Dapoxetine for the Treatment of Premature Ejaculation: Integrated Analysis of Results from Five Phase 3 Trials
    McMahon, Chris G.
    Althof, Stanley E.
    Kaufman, Joel M.
    Buvat, Jacques
    Levine, Stephen B.
    Aquilina, Joseph W.
    Tesfaye, Fisseha
    Rothman, Margaret
    Rivas, David A.
    Porst, Hartmut
    JOURNAL OF SEXUAL MEDICINE, 2011, 8 (02): : 524 - 539
  • [28] Tapinarof cream for the treatment of atopic dermatitis: Efficacy and safety results from two Japanese phase 3 trials
    Igarashi, Atsuyuki
    Tsuji, Gaku
    Fukasawa, Shuichi
    Murata, Ryusei
    Yamane, Satoshi
    JOURNAL OF DERMATOLOGY, 2024, 51 (11): : 1404 - 1413
  • [29] Efficacy and safety of avacincaptad pegol in patients with geographic atrophy (GATHER2): 12-month results from a randomised, double-masked, phase 3 trial
    Khanani, Arshad M.
    Patel, Sunil S.
    Staurenghi, Giovanni
    Tadayoni, Ramin
    Danzig, Carl J.
    Eichenbaum, David A.
    Hsu, Jason
    Wykoff, Charles C.
    Heier, Jeffrey S.
    Lally, David R.
    Mones, Jordi
    Nielsen, Jared S.
    Sheth, Veeral S.
    Kaiser, Peter K.
    Clark, Julie
    Zhu, Liansheng
    Patel, Hersh
    Tang, Justin
    Desai, Dhaval
    Jaffe, Glenn J.
    LANCET, 2023, 402 (10411): : 1449 - 1458
  • [30] Safety and efficacy of albiglutide—results from two trials
    Giuseppe Derosa
    Pamela Maffioli
    Nature Reviews Endocrinology, 2014, 10 : 514 - 516
12345